News | March 02, 2024
Cipla incorporates JV company in USA
Cipla completes transfer of Generics Business Undertaking
Cipla completes transfer of Generics Business Undertaking
BHL will undertake the development and supply of these molecules
The objective of GCMC is well aligned to WHO’s call to action and India’s National Biotechnology Development Strategy
_in_Mizushima,_Japan_256_384.jpg)
Contributing to lower risk of potentially carcinogenic nitrosamine impurities in pharmaceuticals
The plant will drive pharmaceutical innovation in the Northeastern India
Academic and Policy Research to get further boost, RIS will bring forth Ayush Service Sector report soon
Pfizer INDovation program partners with NIPER Ahmedabad to incubate healthcare startups
The said Unit complies with the prescribed Good Manufacturing practices as per relevant WHO technical Report Series
Suven Pharmaceuticals’ API and forumulations facilities complete USFDA inspection successfully
Net product sales in the fourth quarter of 2023 include the recognition of $0.6 billion from deferred revenue, related to Gavi, the Vaccine Alliance
Subscribe To Our Newsletter & Stay Updated
